What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Type 2 diabetes
Philip Home spends much of his time researching Internal medicine, Diabetes mellitus, Endocrinology, Insulin and Type 2 diabetes.
Internal medicine is closely attributed to Surgery in his work.
His biological study spans a wide range of topics, including Anesthesia, Heart failure, Transplantation and Intensive care medicine.
His work deals with themes such as Pharmacokinetics and Crossover study, which intersect with Endocrinology.
The concepts of his Type 2 diabetes study are interwoven with issues in Gastroenterology, Alternative medicine, Clinical endpoint, Rosiglitazone and Glycemic.
Philip Home interconnects Morning and Insulin lispro in the investigation of issues within Insulin glargine.
His most cited work include:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) (14520 citations)
- European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. (2004 citations)
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial (1112 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Diabetes mellitus, Endocrinology, Insulin and Type 2 diabetes.
His research on Internal medicine often connects related areas such as Type 1 diabetes.
His studies in Diabetes mellitus integrate themes in fields like Surgery, Gerontology, Family medicine and Intensive care medicine.
His work on NPH insulin, Pancreatic hormone and Metabolism as part of his general Endocrinology study is frequently connected to Evening, thereby bridging the divide between different branches of science.
His Insulin research integrates issues from Meal and Glucose control.
He mostly deals with Insulin detemir in his studies of Type 2 diabetes.
He most often published in these fields:
- Internal medicine (59.58%)
- Diabetes mellitus (49.42%)
- Endocrinology (46.42%)
What were the highlights of his more recent work (between 2011-2021)?
- Internal medicine (59.58%)
- Type 2 diabetes (30.48%)
- Diabetes mellitus (49.42%)
In recent papers he was focusing on the following fields of study:
Philip Home focuses on Internal medicine, Type 2 diabetes, Diabetes mellitus, Insulin and Endocrinology.
His Internal medicine study frequently draws connections between adjacent fields such as Basal insulin.
His Type 2 diabetes study combines topics from a wide range of disciplines, such as Gastroenterology and Pediatrics.
His work carried out in the field of Diabetes mellitus brings together such families of science as Observational study, Gerontology, MEDLINE and Intensive care medicine.
The Insulin study combines topics in areas such as Weight gain, Glucagon-like peptide 1 receptor and Bioinformatics.
His Endocrinology research incorporates themes from Non interventional and Pharmacodynamics.
Between 2011 and 2021, his most popular works were:
- 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD) (719 citations)
- Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin A 24-week, randomized, placebo-controlled comparison (GetGoal-l) (236 citations)
- New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1) (232 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Type 2 diabetes
His primary areas of study are Internal medicine, Diabetes mellitus, Type 2 diabetes, Insulin and Endocrinology.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Placebo.
He has researched Diabetes mellitus in several fields, including MEDLINE and Intensive care medicine.
His Type 2 diabetes study incorporates themes from Alternative medicine, Surgery, Disease and Specialty.
His study in Endocrinology is interdisciplinary in nature, drawing from both Animal data, Malignancy and Bioinformatics.
Philip Home has included themes like Insulin glulisine, Postprandial, Insulin aspart and Insulin lispro in his Pharmacodynamics study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
